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ABSTRACT 
 Sickle cell anemia patients face disproportionate disparities in health care. 
Treatment for adult sickle cell disease (SCD) patients is mainly palliative (alleviating 
pain symptoms) without addressing underlying causes. Cognitive influences (e.g., 
knowledge, belief, attitude, and intentions) and systematic barriers often determine 
healthcare practices and quality of care. Gaining the healthcare providers’ perspective on 
the social and systematic influences on the implementation of comprehensive 
coordinated care, a highly regarded disease management model, might be key to 
understanding stagnant health outcomes among adult sicklers. Caribbean Island nation’s 
providers’ treatment of SCD patients results in optimal health outcomes. Hence, 
Caribbean treatment providers can provide insight into improving the delivery of 
healthcare in the USA.  
The purpose of this study is to describe Trinidadian SCD healthcare providers’ 
cognitive influences and systematic barriers to implementing coordinated comprehensive 
care. A purposive sample of 5 male and female SCD practitioners in Trinidad were 
interviewed by UWI – St. Augustine researchers. Data saturation was achieved by the 
end of the third interview. Utilizing Colaizzi’s method of phenomenology to perform a 
secondary data analyses of informative research, rigor was established through the 
application of authentication, justification, and validity.  
Eight themes arose from 91 significant statements. Cognitive influences 
included: knowledge and promotion of preventative care; emphasis on beliefs of 
effective patient-provider communication; and positive attitudes regarding patient 
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autonomy, self-care management, and comprehensive care. Barriers included: lack of 
resources and support; lack of consensus on standards of care, including proper pain 
management; social stigma; and accessibility to quality care.    
Understanding these social and structural influences and barriers to the 
implementation of coordinated comprehensive care from the perspective of the 
healthcare provider might help stakeholders identify viable solutions to improve adult 
sickle cell patients’ quality of life and provide efficient, yet effective, treatment. 
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CHAPTER I 
 INTRODUCTION  
 
Purpose 
The purpose of this secondary data analysis of informative research is to identify, 
understand and describe the cognitive and social influences toward the implementation 
of medical and non-medical practices, including barriers to implementing 
comprehensive coordinated care amongst sickle cell disease (SCD) adult healthcare 
providers in areas where comprehensive care is either limited or unavailable using 
phenomenological research methods. Particularly, this study will seek to illuminate the 
dynamic lived experience as an adult SCD healthcare provider in areas where utilization, 
quality of care, and access to coordinated comprehensive health services are heavily 
dependent on geographic proximity and socioeconomic status. This study will help 
healthcare professionals and stakeholders to understand healthcare providers’ 
experiences and how barriers to coordinated comprehensive care affect medical and non-
medical practices, health outcomes, and quality of life (QOL) in adult SCD patients. 
This study will also suggest ways to develop strategies to meet the needs of the patient. 
Improving disease management strategies amongst healthcare providers can ultimately 
lead to achieving improved health outcomes and QOL for all adult SCD patients. 
Significance 
 This research study’s findings will describe healthcare providers’ lived 
experiences in implementing coordinated comprehensive care within Trinidad and 
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Tobago. This study will also highlight providers’ perspectives on how the lack of 
coordinated comprehensive care for underserved, disadvantaged populations affects 
health outcomes, medical practices, and organizational processes. 
Research Questions 
 Assuming that participants are aware of the benefits regarding the 
implementation of comprehensive coordinated healthcare services, how do 
attitudes, beliefs, and knowledge capacity of adult SCD healthcare specialists 
influence the implementation of coordinated, comprehensive care?  
 How are standard of care practices reinforced in areas where coordinated, 
comprehensive care is limited or non-existent? 
Background 
Comprehensive coordinated care is an integrated model of multidisciplinary 
healthcare that includes the implementation and integration of the chronic care model 
and the concept of a medical home (Mvundura, 2009). The benefits of coordinated 
comprehensive care for individuals with sickle cell disease, the most common genetic 
disorder in the world, and other genetic disorders (e.g. cystic fibrosis, hemophilia) have 
been documented on both a national and global scale, with positive consensus regarding 
its implementation by healthcare practitioners (Serjeant, 2001; Okpala, 2002). 
Comprehensive coordinated care specialty centers are the only facilities where 
coordinated, quality care for SCD adult patients is usually available, due to its 
requirements of clinical experience and expertise (Grosse, 2009; AAP, 2002; NIH 2002; 
Okpala, 2002; Claster, 2003). 
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CHAPTER II 
LITERATURE REVIEW 
 
 
Sickle cell disease is the most prevalent genetic disorder in the world and is 
composed of a group of inherited genetic blood disorders, also known as 
hemoglobinopathies or dysfunctional red bloods. The abnormally shaped red blood cells 
in SCD patients have shortened lifespans, causing anemia. During what is known as a 
pain crisis, these abnormal red blood cells act as a blockade within the blood vessels, 
restricting the flow of necessary oxygen and other nutrients. Sickle cell disease has 
several variations (SS, SC, beta thalassemia etc.). Disease severity is heavily dependent 
upon the variation of SCD (Sergeant, 2013). Common manifestations of SCD are severe 
acute and chronic complications, as well as other multi-systemic health issues. These 
complications include the unpredictable occurrence of vas-occlusive pain crisis, an 
increased likelihood of stroke, ischemic organ damage, multisystem morbidity, 
psychosocial stressors, and early death (Sergeant, 2012). Currently, there is no cure for 
SCD. 
SCD affects millions of people around the globe, primarily people of African, 
Sub-Saharan, Mediterranean, Saudi Arabian, Indian, Southeast Asian, South/Central 
American, and Caribbean descent (CDC, 2014). Variation of the disease is a useful 
indicator of ancestry for Black SCD patients (Sergeant, 2013). Recent literature has 
reported that 5% of the human population and 7% of pregnant mothers carry a 
hemoglobinopathy. Annually, 330,000 babies are born worldwide as a sickle cell trait 
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(SCT) carrier, with 275,000 actually diagnosed with the disease (Modell, 2008). Today, 
the average life expectancy that has been accepted by the medical community for those 
affected by SCD is 42/48 years (men/women)—a sharp contrast to an average life 
expectancy of 20 years old and high rates of infant mortality reported in earlier years 
(Platt, 1994). Reports were significantly better in a Jamaican study, with average life 
expectancy for men of 53 years and of 58.5 years for women (Wierenga, 2001).  
SCD occurs when the child has inherited one sickle cell gene from each parent. 
Those who only inherit one SCD gene and a normal gene can carry the sickle cell trait, 
which is not the same as carrying the disease. Trait carriers are asymptomatic, and 
usually live normal, healthy lives, but can pass the sickle cell trait on to their offspring.  
In the United States, SCD affects roughly 100,000 people, with nearly 2 million trait 
carriers (CDC, 2011). In the U.S., African-Americans comprise the racial majority of 
SCD populations (CDC, 2011). Annually, SCD occurs in one out of 500 African-
American births, and one out of 36,000 Latino American births (CDC, 2014).  Gene 
carriers, or those with the sickle cell trait is present in one out of every 12 persons of 
Black or African descent (CDC, 2014). SCD occurs in one out of every 2,474 births in 
the U.S. overall (Therrell, 2006; Oyeku, 2014).  
Within the Caribbean islands, where the majority of the population are of West 
African descent, the homozygous haplotype SS is the most common variation of SCD. 
The most current incidence rates for SCD are 1:300 (HbSS), 1:500 (HbSC), 1:3000 (Sb+ 
thalassemia), and 1:7000 (Sb0 thalassemia) (Serjeant, 2001). The SCD carrier trait for 
haplotype SS is found in 10% of the population, 3.5% of the population for haplotype 
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SC (Serjeant, 2001). Similar rates were also found on the Caribbean island of Barbados 
(Quimby, 2014). 
Current Medical Treatment 
Much of the medical advances and improvements in health outcomes related to 
those affected by sickle cell anemia are due to the implementation of newborn screening 
programs, quality medical care, increased awareness and education, dissemination and 
publication of health care information from SCD specialty centers, and the use of 
prophylaxis penicillin and hydroxurea (Jeanerette, 2011; Oyeku, 2012; Koshy, 1996). 
However, longstanding treatment has been considered to be sedative, only relieving 
acute symptoms while neglecting the underlying cause of the adverse disease 
manifestations (Claster, 2003). Clinical management of vas-occlusive crisis, the most 
common reason for hospitalization, includes a case specific treatment combination of 
increasingly unacceptable narcotics as pain medications (opiates), blood transfusions as 
needed, and constant hydration (Stinson, 2003). Although bone marrow transplants are 
costly, limited in donors, and not guaranteed, it is the only option currently available to 
reverse diagnosis (Nietert, 2002). QOL, mortality, and health outcomes of adult SCD 
patients vary across institutions and populations where affected individuals reside 
(Oyeku, 2012). Many high income and developing countries now have patients that are 
living longer than previously, demonstrating a need to understand the complete etiology 
of the disease, factors that influence increased morbidity as this population ages, and a 
more collaborative effort in using multidisciplinary approaches to improve health 
outcomes, including the QOL as the patient ages. 
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Benefits of Coordinated Comprehensive Care 
The benefits of coordinated comprehensive care for individuals with sickle cell 
disease and other genetic disorders (i.e. cystic fibrosis, hemophilia) have been 
documented on both a national and global scale, with positive consensus regarding its 
implementation by healthcare practitioners (Okpala, 2002). Comprehensive specialty 
centers are the only facilities where coordinated quality care for SCD patients is usually 
available, due to its requirements of clinical experience and expertise. Comprehensive 
coordinated care is an integrated model of multidisciplinary care that includes the 
implementation of the chronic care model and the concept of a medical home 
(Mvundura, 2009). Model comprehensive coordinated care for SCD addresses each facet 
of health and should include a multidisciplinary team that functions based on the 
interactions between medical and non-medical services and the patient (Mvundura, 
2009; Okpala, 2002). The coordinated medical team includes a specialty physician 
(hematologist), physician’s assistant, health educator, social worker, access to laboratory 
and radiology services, as well as a 24-hour blood bank service (Mvundura, 2009). This 
type of coordinated care suggests that different facets of comprehensive care and other 
needed health services are cohesively delivered, essentially utilizing a more strategic, 
unified approach to improving health outcomes for SCD patients. If resources permit, 
this approach can be used in a medical home to its entirety; otherwise, collaboration with 
SCD specialty care centers and other subspecialty services is highly recommended 
(Grosse, 2009). It is important to note that US researchers have demonstrated the cost 
effectiveness of comprehensive coordinated care through economic comparison analysis 
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of utilization patterns and care expenditures between those registered with a local 
comprehensive center and those who only sought episodic treatment (Yang, 1995). The 
number of patients registered with the SCD comprehensive specialty care center 
expenditures was considerably less than those that who received episodic treatment 
(Yang, 1995). Higher standards of care have been observed in specialty health care 
facilities that often only accept private insurance. Coordinated comprehensive care 
centers are often difficult for adult SCD patients to pay for due to public insurance 
limitations, and rarely is re-locating an option in areas where access is limited or non-
existent for a vulnerable population (Mvundura, 2009). Like the U.S., Jamaica, and other 
countries abroad, many dissimilarities and health disparities exist in healthcare across 
the socio-demographic spectrum, particularly amongst those of low socioeconomic 
status, as well as those who live in rural areas with limited access to quality care (Haque 
& Telfair, 2000; Thomas & Lipps, 2011). Individuals affected by sickle cell disease in 
these areas where comprehensive care is limited or non-existent are significantly 
impacted by the burden of disease, including disproportionate rates of poor quality of 
life (McKlish, 2005; Thomas & Lips, 2011; Haque & Telfair, 2000). 
As a result of the implementation and utilization of coordinative comprehensive 
care strategies, although limited in its availability, the positive programmatic, process, 
and health outcomes rendered demonstrate a need for further investigation, as well as its 
widespread adoption across the various health care institutions that serve the SCD and 
SCT populations. This particular model of care has been shown to produce positive 
health outcomes in the Caribbean, specifically Jamaica, as a collaborative partnership 
 8 
 
between the University of West Indies Sickle Cell Unit, Education Centre, and COSCA. 
The collaborative efforts of these organizations and institutions, outlined by the Sickle 
Cell Trust of Jamaica, is supported by the British Medical Research Council and 
National Institutes of Health (NIH) (Serjeant, 2012). Examples of these cost-effective 
care models have been given considerable attention through initiatives such as the 
USA’s Hemaglobinopathy Learning Collaborative, whose main goal is to improve the 
health outcomes and quality of life experience for individuals affected by sickle cell 
disease and trait carriers, a collaborative effort supported by the National Heart, Lung, 
and Blood Institute (NHLBI), the Health Resources and Services Administration 
(HRSA), the National Institute for Children’s Health Equality (NICHQ), and the Sickle 
Cell Disease Association of America (SCDAA) (Oyeku, 2012).  
Sickle Cell Disease and Health Disparities 
Patients living with SCD also experience a plethora of challenges outside of the 
clinical manifestations of the disease. Many individuals affected by SCD have reported 
discriminatory practices and inadequate care in the healthcare system, school, and work, 
as well as in the socio-environmental realm, at disproportionate rates compared to the 
general population that ultimately negatively affect disease management, QOL, and 
health outcomes (Dorsey, 2001; Tanabe, 2012; Zempsky, 2009; Nelson 2013; Booker et 
al., 2006; Thomas & Taylor, 2002). Disproportionate rates of psychosocial issues—
including depression, social isolation, stigmatization, and low quality of life—have been 
previously reported (Lattimer, 2010; Asnani, 2009; Parwez, 2003; Edwards, 2005; 
Edwards, 2009). Furthermore, individuals affected by sickle cell disease are also likely 
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to report being unemployed, have difficulties sustaining employment, and achieve lower 
rates of higher educational attainment than the general population due to SCD related 
issues, all of which are significantly negative determinants to health (Todd, 2006; 
Herron, 2003).  
Inequitable practices, discrimination, and health disparities are significantly 
associated with negative psychological and physical health outcomes (e.g. pain, stress) 
(Williams, 2009). Worse outcomes have been observed when acts of micro-aggression 
during interaction with the health system recur over a period of time (Zempsky, 2009). 
The stigmatization of and discrimination towards SCD patients resulting from past 
efforts to implement a surveillance program that could potentially improve outcomes in 
various ways as it has for other hemoglobinopathies, continue to raise questions of 
privacy violations and ethical issues (Bowman, 1998). Consequently, efforts to develop 
national registries have become stagnant. For a variety of reasons, including the fear of 
further discrimination and marginalization, many individuals affected by sickle cell 
disease are reluctant to participate in clinical trials and often avoid hospitals until it is 
required (Shavers, 2002; Booker et al., 2006). 
Sickle Cell and the Caribbean Islands 
Regarding the history and success of the advancement in research and practice 
for those affected by sickle cell disease, the Caribbean islands (particularly Jamaica) are 
considered leaders in transforming the disease from debilitating and unpromising, into a 
condition that can be effectively managed and controlled (Serjeant, 2012). While 
available resources for the Caribbean are incomparable to developed, high-income 
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countries such as the USA, literature states that according to a Jamaican clinic based 
population study, survival estimate rates are similar if not better than those the USA 
(Wierenga, 2001). Participating sickle cell disease researchers in Jamaica have also been 
able to develop cost-effective models that can be replicated in poorer countries without 
compromising the quality of care (Sergeant, 2012). The achievements made by these 
researchers have been recognized globally. These researchers have been able to assist in 
the development of similar programs for countries across Africa, South America, and the 
Middle East (Seargent, 2012). Multi-site programs have assisted in the development of 
sickle cell services such as newborn screening programs, interventions using 
pneumococcal prophylaxis, early detection of acute splenic sequestration education 
programs, and premarital genetic counseling prevention services. Given the proper 
dedication and commitment of healthcare systems and healthcare providers to the 
implementation of coordinated comprehensive care, along with dedicated efforts toward 
the expansion of sickle cell disease research capacity, improvements in practice, and 
strategic community health education and promotion, success stories have been 
extensively documented by countries abroad utilizing such models of care (Rahimy, 
2003; Sadarangam, 2009). 
Much of the research available for SCD that has been performed in the Caribbean 
has been population specific to Jamaica. The majority of available research is 
quantitative, only concentrating on the quantifiable and genetic manifestations of the 
disease. Despite the need for more qualitative studies related to SCD, suggested by 
Thomas and Taylor (2002), to date there has only been one publication to this 
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researcher’s knowledge using qualitative research methods, a study performed in 
Jamaica, and none in the surrounding Caribbean islands (Anderson, 2013). Although 
there has been increased awareness and programs dedicated to sickle cell disease 
throughout the Caribbean islands, most notably the Caribbean Organisation of Sickle 
Cell Associations (COSCA), Jamaica is the only island within the Caribbean that 
provides infrastructure dedicated specifically to the comprehensive care and treatment of 
individuals with sickle cell disease (Serjeant, 2012). This researcher has been unable to 
locate research literature, programs, and initiatives specific to the SCD population in 
Trinidad and Tobago, which more than likely do not exist. To illuminate the experiences 
of healthcare providers in the Trinidad and Tobago, where coordinated, comprehensive 
care for adult SCD patients is either limited or non-existent, researchers have employed 
qualitative research methods. Qualitative studies are able to capture the true essence of 
the experience of individuals affected by SCD and allow healthcare providers to develop 
strategic approaches to addressing apparent issues and disparities. The findings from this 
study will address the scarcity of Trinidad and Tobago-specific data, as well as the need 
for more qualitative reports to understand the lived experiences of individuals affected 
by sickle cell disease. 
Specific Aims 
1. To describe the components of coordinated comprehensive care used to improve 
health outcomes for chronically ill patients. 
2. To assess the knowledge, beliefs, and attitudes towards disseminating coordinated 
comprehensive care strategies and their implementation amongst SCD healthcare 
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providers through secondary data analyses of key informant interview transcriptions 
collected by UWI researchers using qualitative methods of analyses. 
3. Identify coordinated comprehensive care practices and strategies amongst adult SCD 
healthcare providers. 
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CHAPTER III 
RESEARCH DESIGN AND METHODS 
 
With Texas A&M University Institutional Review Board approval of data that 
had been previously collected, reference IRB2015-0252, the proposed cross-sectional 
study design will include a secondary data analyses of informative research provided by 
UWI researchers. Specifically, TAMU researchers will analyze the transcriptions of 
local adult sickle cell disease healthcare providers, a data set that is part of a study 
previously conducted in Trinidad and supported by the University of West Indies—St. 
Augustine. Although the following study is a secondary data analyses, two TAMU 
HLKN graduate students took part in the primary data collection process protocol, and 
provided research assistance to the Principal Investigators of the UWI- St. Augustine 
research team. The assistance provided by the graduate students was in fulfillment of 
partial requirements for the TAMU HLKN-sponsored study abroad course held in 
Trinidad and Tobago. The original intention of the data provided in this research study 
was for formative thesis development purposes only, and was not meant to be used for 
analytical reasons, but rather to guide the development of the questionnaire for the 
original thesis study proposal. For these reasons, IRB approval was not required for the 
graduate students to participate in the primary data collection process protocol of the 
research performed in Trinidad and Tobago.  
A change in the study focus (which is common for mixed methods research and 
qualitative studies) led to the need to utilize the data that are being presented as 
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secondary analyses. As a result of the aforementioned change in study focus, 
participating study researchers from both institutions came to the consensus that IRB 
approval was necessary before the data that is being presented could be utilized. IRB 
approval, reference IRB2015-0252, was then obtained from both Texas A&M University 
and the University of West Indies- St. Augustine for secondary data analyses utilization 
purposes.  
The settings for the interviews were determined at the physicians’ discretion. 
Recruitment efforts garnered a total of five eligible participants. Out of the overall five 
interviews, three took place within the offices of their respective private practices, one 
was held in a private office at the Eric Williams Medical Services Complex, and the last 
interview took place on the campus of University of West Indies—St. Augustine. 
According to the majority of the participants, there is a total of about 15 hematologist on 
the islands of Trinidad and Tobago who specifically treat adult individuals affected by 
SCD.  
Interviewers utilized in-depth, semi-structured, open-ended, key-informant 
interviews as a qualitative method of data collection. Interview questions and socio-
demographic survey information were guided by previous literature. The instrument was 
validated by experts in minority health issues and health disparities, nutrition, physical 
activity, and health education, and by non-participating adult healthcare professionals 
fluent in qualitative/quantitative research design and application.  
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Site and Sample Selections 
As part of the original data collection protocol (from where the secondary data 
were derived), participating healthcare providers were recruited using the snowball 
sampling method. Recruitment efforts were geared towards sickle cell disease specialty 
clinics and general healthcare facilities. Participants were recruited using solicited 
advertisements that called for willing participants, particularly general and specialty care 
physicians with significant experience in dealing with adult patients with SCD. Ideal 
participants encouraged for inclusion were those who were licensed and practicing 
healthcare providers, including general physicians and hematologists with substantive 
experience in dealing with adult SCD patients. Those excluded from participating in the 
research study were non-practicing/unlicensed healthcare providers with little experience 
in dealing with patients with SCD. 
The settings for the interviews were determined at the physicians’ discretion. 
Trinidad was selected to be the site of the research study. Recruitment efforts garnered a 
total of five eligible participants. Out of the overall five interviews, three took place 
within the offices of their respective private practices, one was held in a private office at 
the Eric Williams Medical Services Complex, and the last interview took place on the 
campus of University of West Indies—St. Augustine. According to the majority of the 
participants, there is a total of about 15 hematologist on the islands of Trinidad and 
Tobago who specifically treat adult individuals affected by SCD.   
Finally, eligible participants voluntarily participated in an audiotaped, 30-minute 
to one-hour interview and asked a range of questions related to the aforementioned 
 16 
 
research agenda (see Appendix A). For the participants’ protection, this study was 
completely anonymous and does not contain any identifiers. All materials and data 
deemed confidential were collected and stored by key personnel and used only within 
the guidelines provided by the Institutional Review Board and the research study’s 
Principal Investigator.  
Data Analysis 
In an attempt to understand how a given phenomenon is experienced, in this case 
the implementation (or lack thereof) of coordinated comprehensive specialty centers and 
programs for SCD patients, data was collected and analyzed using the phenomenological 
method. Phenomenology seeks to cognize meanings participants connect to a particular 
phenomenon through their lived experiences. Using phenomenology, the researcher 
transcends past knowledge to understand the phenomenon in further detail and consider 
the lived experience with new perspective in hopes of extracting prolific and descriptive 
data from the participant. As adult SCD patients often are cared for by healthcare 
providers, including hematologists and general practitioners, the eligible informants are 
assumed to have considerable knowledge of the healthcare profession, policies, 
practices, and institutional culture that guide their institution. Researcher team members 
speculated that much of the perceived role formation would be developed by healthcare 
professional with direct experience in caring for adult SCD patients. Thus, the 
phenomenological method was deemed appropriate for the analytical purposes of the 
study, as it is founded upon the belief that individuals will attach experiences to meaning 
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of those experiences through reflective memory recall, which are illuminated through an 
analysis of narratives shared by the sample population. 
According to the information provided by the researchers team, study procedures 
included assessment of recruitment, enrollment and eligibility, informed consent, key 
informant interviews, data collection, and data analysis. All interviews were performed 
by one UWI researcher using the interview guide. Probing strategies were also utilized 
to answer study questions if the interviewee did not answer in a way that contributed to 
the research study’s questions. For secondary data analyses, two TAMU assigned study 
investigators meticulously performed line-by-line preparation of data transcriptions, 
categorized findings, and identified undeviating themes. After the themes were 
identified, they were clustered and closely aligned with textual descriptions from each 
individual transcription. Once consensus regarding validity and final themes was 
reached, each theme was then supported and articulated as narrative summaries. Through 
the process of bracketing, researchers then separated their attitudes, beliefs, and 
perceptions from the narrative summaries to be more open to the given phenomenon 
(Figure 1). Table 1 outlines how the questions used in key informant interviews 
produced information to answer study questions related to the implementation of 
coordinated comprehensive care. 
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Figure 1: Phenomenology Process Model (Fortunado-Sanchez, 2002) 
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Table 1. Schematic Table  
Components of Coordinated 
Comprehensive Care (CCC) 
Cognitive Mechanisms That 
Influence CCC 
Implementation 
Interview Questions Utilized 
to Assess Mechanisms that 
Influence CCC 
Implementation 
 Multidisciplinary 
medical team 
 Integrated medical and 
non-medical services 
 Coordinated care 
 Utilization of 
comprehensive care 
strategies 
Knowledge 
 Knowledge of CCC 
 Knowledge of CCC 
benefits and cost 
effectiveness 
Attitude 
 Attitude toward 
implementation 
 Social attitude toward 
implementation 
 Structural attitude 
toward 
implementation 
Behavior 
 Consistency of CCC 
implementation  
 
 
 
 What are some of 
the common 
themes/issues of 
medical practices 
that affect the health 
outcomes of adult 
SCD patients? 
 In an ideal scenario, 
what does high-
quality healthcare 
mean for adult SCD 
patients? 
 What are some of 
the challenges 
healthcare providers 
face in providing 
standardized quality 
healthcare to adult 
SCD patients?  
 How do current 
health policies 
affect the 
experiences of the 
SCD patients 
(access to care, 
healthcare 
utilization, patient-
provider 
communication)? 
Provide examples. 
 What areas of 
improvement in 
healthcare and 
research do you feel 
are needed to 
improve health 
outcomes of SCD 
patients? 
 
 
 20 
 
Data Management 
Researchers vowed to respect and protect subject privacy during the secondary 
data analyses process by obtaining permission from the IRB established under federal 
law and HIPAA. Consent was obtained before any questions were asked or any study 
procedures performed. Participation in the research study depended solely on the consent 
of the participant. Each participant was able to decline participation at any moment in 
the study or interview process; in the event the participant opted to cease participation in 
the study, his/her information and responses were disposed of. The analysis was also 
aggregated with no identifiers to ensure confidentiality of the participants.  
Known Risks/Potential Benefits 
For this particular study, there were no known risks. As this is a secondary data 
analyses, there were no human subjects and no personal identifiers. The potential 
benefits of this study include the creation of a potential guidance tool and resource for 
the future development and implementation of effective, accurate, and appropriate 
coordinated, comprehensive care strategies, policies, and guidelines for patients living in 
areas where specialty clinics are not available; additionally, this study will influence the 
quality and effectiveness of medical practices of primary and specialty care physicians 
of SCD patients from a social and behavioral perspective. This study also seeks address 
disparity gaps in prevention and treatment efforts for patients living with SCD and 
carriers of the SCT, which, if improved, can potentially lead to better health outcomes 
and quality of life and reduce and/or eliminate rates of SCD. The findings from this 
study can also benefit society by potentially improving health outcomes from a social 
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and behavioral perspective for all persons living with both modifiable and non-
modifiable chronic illness, influence other issues related to prevention and intervention 
efforts for minority populations, and enhance the accuracy and effectiveness of medical 
practices amongst general and specialty care physicians who serve underrepresented and 
disadvantaged populations. 
Data and Safety Monitoring 
The data previously collected by the original researcher team, now being used for 
secondary analyses will be stored for 7 years and kept in a safe and secure location that 
is only accessible to its intended recipients, the Principal Investigator (Dr. Jeffrey 
Guidry), and his Graduate Assistant (Ryan Johnson). Following completion of secondary 
data analyses, the data set given to TAMU researchers for secondary analyses will be 
disposed of by shredding and deleting all interview transcriptions used for study 
purposes. 
Anticipated Outcomes 
The anticipated outcomes of this study would be to highlight the different 
practices and theoretical approaches of SCD healthcare providers across nations, which 
could potentially lead to more effective, appropriate, culturally competent, and culturally 
sensitive theoretical approaches, medical practices, and healthcare policies, as well as 
SCD intervention and prevention programs. Researchers hope that the results will 
encourage the use of qualitative methodologies, such as the phenomenological method, 
to address health disparities and ultimately improve health outcomes and quality of life 
for individuals affected by SCD. 
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Communication and Dissemination of Study Results 
Study results will be communicated to the study participants via aggregated 
analysis and format. Confidentiality of responses and specific study results will be 
upheld by all research personnel. Dissemination of results are to include presentation of 
results for local, state, federal, and international health disparities conferences and peer-
reviewed manuscript development. 
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CHAPTER IV 
RESULTS 
 
The research study utilized a data set comprised of interview data from five 
eligible physicians, which included three hematologists and two primary care physicians. 
All participants were assigned pseudonyms.  Out of the five total participants, three 
participants identified as East African Trinidadians, whereas the remaining two 
identified as being of Indian descent. Of the three participating hematologist, two 
possess private practices, while the other practices within the public healthcare system. 
The remaining two participants were general primary care physicians, with one working 
in the public sector, while the other practices privately. Of the five informants, three 
were male, and two were female. The interviews took place at the physicians’ discretion 
and with signed consent. Out of the five total interviews, four interviews took place 
within the offices of their respective private practices, and one interview was held in the 
Hematology Department at the Eric Williams Medical Services Complex. All of the 
participants cited having received British educations and held significant experience in 
treating persons affected with sickle cell disease, with one being an active an active 
researcher of the hemaglobinapathies.  
For the analyses involved as part of the current (thesis) study, data saturation was 
reached at participant three.  A total of eight themes arose from 91 significant 
statements. Best health outcomes and practices were observed when cognitive influences 
included the knowledge and promotion of preventative care, emphasis on patient-
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provider communication, patient autonomy, self-care management, and comprehensive 
care. Observations also revealed poor health outcomes as a result of systematic barriers 
to implementation that included the lack of resources and support, lack of consensus on 
standards of care (including proper pain management), accessibility to quality care, and 
sub-standardized medical practices as a result of cognitive biases influenced by 
psychosocial factors that include social stigma. Table 2 describes the themes revealed in 
detail. 
Table 2. Themes and Descriptions 
Themes Description 
Best Practices  
Recognition and Promotion of Cost/Benefit The continuous implementation of the most 
current, cost-effective medical practices and 
evidence-based approaches to healthcare. 
Effective Patient-Provider Communication Strategies of effective communication between 
the healthcare provider and the patient that is 
culturally competent, culturally sensitive, and 
population specific. 
Emphasis on Patient Autonomy Allowing the patient to provide input and possess 
a sense of personal responsibility in making 
decisions concerning their health. 
Holistic Healthcare Approach An approach to healthcare that addresses each 
facet of health. 
Barriers to Implementation  
Inadequate Resources and Funding The lack of organizational, financial, political, and 
social support to address pertinent health 
concerns 
Consensus on Standard of Care and Proper Pain 
Management 
A globalized agreement on the definition of quality 
care and proper pain management strategies that 
is also policy bound. 
Accessibility The availability and access to specialty care 
centers that deliver comprehensive coordinated 
care. 
Social Stigma Psychosocial factors that determine health 
outcomes. 
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Best Practices  
Recognition and Promotion of Cost/Benefit 
Participants indicated that recognizing cost-effectiveness in the implementation 
of comprehensive coordinated care and its benefits not only prevents frivolous and 
unnecessary expenditures, but also positively influences compliance in proper self-care 
disease management.  
“My practicing guidelines really are to maintain the health of the patient as well 
as to prevent a crisis from taking place.” -- Interview #1 
 
“One thing I do is to teach them of the things that could bring a crisis on and 
how to avoid them, how to recognize them and what actions should be taken.”-- 
Interview #2 
 
“I think the cost that goes along with SCD can be understood anyway anywhere-
most importantly, understanding that it could improve the economy by improving 
the healthcare of the sickle cell disease patient.”-- Interview #2 
 
Participants stressed the importance of integrating coordinated, comprehensive 
health services as a means of managing SCD. By utilizing clinical and non-clinical 
strategies that address acute and chronic complications, as well as its subsequent psycho-
social factors, data supports the idea that comprehensive coordinated care leads to both 
positive health outcomes and favorable economic conditions for program sustainability 
(Yang, 1995; Serjeant, 2012; Gross, 2009). 
Effective Patient-Provider Communication 
Participants indicated that recognizing and promoting effective patient-provider 
communication is an integral part of disease management and must not be compromised. 
Communication that is not overbearing and is both culturally sensitive and culturally 
competent produces significant, optimal results in compliance and patient autonomy.  
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“Every child that comes through my office, comes to me as my child, every 
person who comes to me in this office come to me as my mother or my father or 
my brother or my sister-- that is the way I practice.” – Interview #3 
 
“Continuity, communication, and even from the point of view from the patient-- 
now this is the other part of it, one part of it, one part of communication is 
education. If the patient is not educated in terms of what they are to do or 
whether they think he doctor knows what he is talking about, we then run into all 
sorts of problems with compliance.” – Interview #5 
 
Participants noted that by utilizing appropriate language and communication 
strategies that are population specific, health messages and recommendations are 
retained and often lead to positive health outcomes. 
Emphasis on Patient Autonomy 
Informants indicated that particular emphasis regarding patients’ autonomy 
should be given considerable attention when delivering health messages. Patients should 
be made to feel that they have control of disease management decisions and given the 
option to consider alternative therapies without being given an ultimatum. 
“I have to be very careful when I counsel because when I counsel, the patient 
must not believe that I am doing it because I want to have [data] or want to 
publish it. The patient must believe that I am doing it because I believe that it is 
best for them.” – Interview #4 
 
Patients want to believe that they are making the best decisions without feeling 
isolated in making a decision influenced by ulterior motives of the healthcare provider.  
Holistic Healthcare Approach  
Participants described the coordinated comprehensive care model as a means to 
address all facets of health, including factors related to the physical, emotional, mental, 
social, occupational, and spiritual determinants of health. 
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“It is important that I communicate to the patient to engage one’s self in 
activities that would maintain good health and promote good health in all 
aspects—you see there are different things. You have the nutritional health 
component, the mental health component, sexual health component, 
relationships, psychological and in all different aspects and spheres because we 
as humans have a social component—emotional, mental, physical, and spiritual--
so it’s really to engage and live a well-balanced life.” Interview #1  
 
Participants recognized that addressing the health of individuals affected by SCD 
from a holistic perspective allows both the provider and the patient to engage in effective 
communication to improve health outcomes and reduce disease-related morbidity. 
Barriers to Implementation 
Inadequate Resources and Funding  
In response to the most challenging issues in research and practice that lead to 
poor health outcomes among individuals affected by sickle cell disease, participants 
noted that providers are not only oblivious to the need for improving practice, but are 
often ill-prepared to manage a disease that requires specific expertise and effort. Limited 
resources and inadequate compensation give health providers little incentive to 
implement health services, such as coordinated comprehensive care deemed necessary 
for quality care. 
“It is too many people in this country that we do not have. Institutions that are 
devoted to or adequately staffed by people who don’t believe that chronic ailment 
are things that we can ignore, and that what is happening.” – Interview #5 
 
“Like anybody who is trained, including in Sub-Sahara Africa, nobody 
particularly trains anybody in anything about SCD. Nobody cares about SCD, 
and I happen to know that that’s in the first world, too. They do not. And as such 
they get a lot of substandard care because nobody bothers to learn how to do 
that.” – Interview #4 
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Participants concluded that because of the lack of fiscal and operational support, 
healthcare providers are often uninterested in improving care strategies and 
implementing comprehensive coordinated care. Few incentives have caused many 
researchers and healthcare providers to neglect taking the time out to expand the scope 
of prevention, treatment, and disease management. 
Consensus on Standard of Care and Proper Pain Management 
Lack of united consensus on standard of care guidelines and proper pain 
management lends to the various discrepancies in care across institutions that provide 
care for adult SCD patients. Currently, there are no set policies or guidelines that govern 
how health care should be delivered to such a vulnerable population, despite the 
disease’s long history of discrimination towards and marginalization of affected 
individuals within the clinical setting. 
“One of the biggest challenges in standardizing quality care is having a sense of 
standards, written standards--disseminated and agreed upon.” –Interview #2 
 
“You have doctors managing SCD who do not know their gluteus maximus from 
their elbow or about how a crisis occurs in these conditions and why some 
patients do not get crisis. So you have excuses for hematologist working in the 
system--the whole system is a professional system all about how much money you 
can make out of it and how quick you can get your hospital work done.” - 
Interview #3 
 
“In addition to not speaking to them, not to find out anything about them; just 
give them folic acid and penicillin and send them off. If they are having a crisis, 
send them to the ward. There is no compassion--nothing is done to help the 
patient to this day!”-Interview #3 
 
“We believe that one of the biggest things we need to do in the Caribbean is have 
proper pain management. People don’t understand that if I'm going to stop a 
vas-occlusive crisis-- I am going to stop it. And when I stop it I have given you 
enough narcotics to turn you into an addict and therefore all I do is ensure that I 
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reverse it by weaning you off the drug before I set you off. Now the big problem I 
think in the U.S.--too many rights.” Interviewer #4 
 
Each patient is treated differently. No two sicklers are the same. No two SC’s are 
the same. So think I look at each patient totally individually, I make no 
comparisons. Because they are different, their pain threshold is different, 
everything is different.” –Interview #3 
 
Participants stressed the importance of the development and dissemination of 
written, viable solutions to quality care and treatment strategies that should also include 
policies related to accountability and adherence on behalf of the healthcare provider. 
Because patients are unique to the variant of the disease and a vulnerable population 
who are more likely to experience adverse socioeconomic and psychosocial 
circumstances, establishing consensus regarding standard of care practices and proper 
pain management will aid in achieving optimal health outcomes and health equity across 
all institutions providing care. 
Accessibility 
Study informants also described limitations in accessibility to coordinated 
comprehensive care centers due to both geographical proximity and insurance coverage. 
Adult SCD patients are limited in what care they receive, depending on if nearby 
specialty centers accept government-sponsored insurance coverage. Participants 
indicated that most patients frequently identify emergency rooms and hospitals as 
primary care facilities, which can be problematic in regards to receipt of sub-
standardized care that is often delivered in such settings. 
“The current practices are hit and miss. Utilization--there are enough 
institutions that would be able to provide more than adequate care for people 
with SCD. That is a very complex issue whether the quality of that care that you 
are being provided is accessible . . . the access available to the medical fraternity 
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should, and I am saying that very carefully, should have more than enough 
practice and knowledge base on how to manage SCD.”–Interviewer #4 
 
Informants indicate that although organizational structure allows the 
implementation of coordinated comprehensive care, adult SCD patients are less likely to 
access such care due to apparent internal biases in providing quality care. Although 
many institutions are aware of effectiveness and cost/benefit of comprehensive care and 
are more than capable of providing such services, many simply choose not to for 
apparent economic and social reasons.  
Social Stigma 
Lastly, researchers identified issues related to the social stigmatization of having 
SCD that often affects the level of care provided to the patient. Participants note that 
many issues are exacerbated in areas where socioeconomic status, race, and gender 
influence medical practices and quality of care. 
“Many of the common themes or issues in SCD patients is that a lot of it is 
psychosocial. Psychosocial from the stigmatization of the disease. . . . People 
who hold the highest offices in the land you wouldn’t know because it is 
stigmatized. If I am a serious high court judge I wouldn’t tell anyone because it 
might be used against me in one of my judgments.”–Interview #4 
 
“If you want to ask me about sickle cell, it’s not just about sickle cell. It’s a lot 
more than that. It’s the extension into the society.”–Interview #5  
 
Barriers to coordinated comprehensive care should be addressed across the healthcare 
spectrum, as well as its accompanying systematic limitations and extension into the 
greater society. Information provided by participants suggest that until healthcare 
providers consider serious action and gain full understanding of its effects on 
organizational economics and processes, health outcomes, and overall quality of life, 
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adult sicklers will continue to report problematic experiences that will, sadly, equate to 
poor health outcomes, increased mortality, and disease-related morbidity. 
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CHAPTER V 
DISCUSSION 
 
Such factors that influence the implementation of comprehensive care for adult 
individuals affected by SCD mean that patients are not only adversely affected by the 
disease and its complications, but also by other systematic issues within healthcare and 
deeply woven racial prejudices that ultimately widen the disparity gap between the 
current situation and improving future research, medical practices, and the health 
outcomes of SCD patients. The results of this study demonstrate how evaluation and 
assessment of cognitive influences and medical practices of healthcare providers of adult 
SCD patients in areas where comprehensive coordinated care is limited or non-existent 
is needed to improve organizational processes, patient health outcomes, and quality of 
life. Healthcare providers’ experience advises their reciprocal action with adult SCD 
patients, including prevention, intervention, management, treatment strategies, and 
patients’ health outcomes and quality of life, as well as the administrative and 
organizational processes and culture of the institutions that service this population. 
Therefore, the healthcare provider of adult SCD patients must be functionally capable 
and willing to implement coordinated comprehensive care, a strategy that has shown to 
be both efficient and effective (Grosse, 2009). As suggested by study participants, the 
implementation of coordinated comprehensive care is necessary to reduce morbidity and 
mortality rates of SCD, reduce incidence and prevalence rates, and, ultimately, improve 
health outcomes and quality of life for the existing adult SCD population. 
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Recommendations for Future Research 
The results of this study indicate that further research is needed to illuminate the 
experience of adult SCD patients in areas where comprehensive coordinated care is 
limited or non-existent in order to document the differences in the care received. To do 
this, stakeholders, healthcare providers, and SCD philanthropic support groups must 
work collaboratively to build the funding and research capacity of the adult SCD 
population. The documentation of these experiences would describe the extent of 
improvement in health outcomes and quality of life for patients who are seen in 
institutions that have allocated coordinated comprehensive care programs and facilities 
for the adult SCD population. The results of such documentation will build a case for the 
universal adoption of coordinated comprehensive care as a standard of care policy. 
Furthermore, this study also illustrates the need to research the experiences of 
adult individuals affected by SCD and their healthcare providers in other countries 
throughout the West Indies and abroad through the use of both quantitative and 
qualitative research methods in clinical and non-clinical settings. Such studies should 
illuminate the health behaviors of adult SCD patients, particularly describing the residual 
effects that stem from the system’s outright neglect to address the need for 
multidisciplinary healthcare across all institutions that serve the SCD populations, as 
well as its influence on health outcomes and health behavior. Similarly, further studies 
are needed to identify, describe, and address the residual effect of the continued reliance 
on heavy opioids and narcotics (i.e. morphine) that is used consistently to alleviate pain, 
particularly its influence on the health behavior and health outcomes (including QOL) of 
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at-risk individuals affected by SCD in areas where comprehensive coordinated care is 
limited or non-existent. Particular emphasis should be placed on documenting the lived 
experiences of the portion of the population with severe cases of disease manifestation 
and its greater dynamic extension into the individual’s environment and respective 
societal structure. 
Recommendations for Future Practice 
Additionally, this study demonstrates the need to perform a thorough evaluation 
assessment of the curriculum and training programs that are teaching the healthcare 
providers of this population in order to identify gaps in learning objectives and 
instructional opportunities to better serve the adult SCD population. General consensus 
on adequate training and standard of care practices to improve the quality of care 
rendered should be obtained. The findings of such a study should also reflect how the 
identified gaps in curriculum and instruction of healthcare providers of individuals 
affected by SCD translate to research and practice, as well as to recommendations that 
address the identified emergent issues. 
Furthermore, additional evaluation assessment studies that would describe in 
detail the expenditures and fiscal practices of healthcare providers of adult SCD patients 
are needed to document issues related to accountability and intention. Studies suggest 
that implementation of coordinated comprehensive care is, in fact, cost-effective in 
comparison to episodic treatment, and these studies have documented a complete cost-
benefit analyses to support such claims (Yang, 1995). Healthcare providers are 
essentially compensated significantly higher wages as a result of high expenditures to 
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deliver substandard care, despite the fact that it is considerably cheaper to implement the 
specialty care required in order to achieve optimal health outcomes and positive reports 
of quality of life among the adult SCD population. This should raise ethical concerns. 
Questions surrounding the way providers are rewarded or compensated in terms of 
patient health outcomes should be addressed to understand doctors’ incentives to 
implement coordinated comprehensive care. Such studies would also illuminate the 
experiences of healthcare providers and their respective perspectives in terms of 
identifying and describing prevention efforts, social support and philanthropic initiatives, 
health promotion, and health advocacy in ways that would address negative determinants 
of health as well as the gaps in the services rendered. As a result, such suggestions may 
produce viable, efficient, and effective solutions to improving the overall health 
outcomes and quality of life among adults affected by SCD. 
Study Limitations 
Because the research design included cross-sectional survey methods, only a 
glimpse or snapshot of the illuminated experiences of the healthcare provided is 
available for analyses. Researchers are unable to explore how such issues are 
experienced over a period a time and can only infer how the information collected has 
come to be as a result of longstanding and continuing cognitive influences and practices. 
Another limitation is that, by performing a secondary analyses, researchers were 
unable to capture both verbal and nonverbal nuances of the participants. Such nuances 
could possibly illuminate the emotional component of information shared that, in turn, 
would evoke the passion of the adult SCD healthcare providers in implementing 
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coordinated comprehensive care (or in expressing the lack thereof) and its effects on the 
patients for whom they care. 
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CHAPTER VI 
CONCLUSION 
 
Individuals affected by sickle cell disease, specifically adults, receive variant 
healthcare services. Adult patients in areas where coordinated comprehensive care is 
limited or non-existent are more likely to be disengaged with the healthcare system and, 
as a result, often report adverse health outcomes and poor quality of life. Understanding 
the cognitive influences and medical practices of adult SCD providers can provide a 
resource tool for identifying quality care strategies to achieve optimal health outcomes, 
as well as to address structural, social, and cultural barriers in implementing efficient, 
yet effective, comprehensive coordinated care. Such findings can also lead to evidence-
based policy development and the reorganization of institutional processes to better meet 
the needs of adult SCD patients. This study demonstrates that healthcare providers are 
the gatekeepers of knowledge and understanding how the residual effects of care 
rendered affect adult SCD patients and play a pivotal role in improving health outcomes 
and quality of life of adult individuals affected by sickle cell disease. 
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APPENDIX A 
KEY INFORMANT INTERVIEW GUIDE 
 
BASELINE 
1. What is your occupation/profession? 
2. How long have you been practicing in the healthcare profession? 
3. What is your medical area of interest or your research interest? 
4. Are you involved in research? Do you sit on any committees or boards? 
5. Do you see SCD patients? If so, how often? 
6. How would you describe your guiding practices or philosophical guidelines as it 
relates to your practice?  
GENERALIST 
1. What are some of the common themes/issues affecting your patients? 
2. Do you encounter a lot of SCD patients in your practice? 
3. Do you give your patients nutritional advice? 
4. Do you give your patients recommendations on physical activity? 
5. Do you give your patients recommendations on sexual activity? 
6. If you have an SCD patient, does your approach change? 
7. In an ideal scenario, what does high quality healthcare mean? 
8. What are some of the challenges healthcare providers face in providing 
standardized quality healthcare to SCD patients? 
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9. What are the most important things you want to communicate to your patients 
and caregivers? 
10. How do current health policies affect the experiences of the SCD patients (access 
to care, healthcare utilization, patient-provider communication)? Provide 
examples. 
11. How do you define success for yourself as a practitioner? 
12. What areas of improvement in healthcare and research do you feel are needed to 
improve health outcomes of patients? 
SPECIALIST 
1. What is the typical routine visit with a SCD patient like? 
2. What is the typical visit with a SCD patient having complications like? 
3. Which do you see more of: children or adults? 
4. Describe the typical SCD patient.  
5. What are some of the common themes/issues that affect health outcomes of SCD 
patients presented to you during a visit? 
6. What are some of the routine questions or protocol when seeing an SCD patient? 
7. Do you give your patients nutritional advice? 
8. Do you give your patients recommendations on physical activity? 
9. Do you give your patients recommendations on sexual activity? 
10. In an ideal scenario, what does high quality healthcare mean for adult SCD 
patients? 
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11. What are some of the challenges healthcare providers face in providing 
standardized quality healthcare to adult SCD patients?  
12. How do current health policies affect the experiences of the SCD patients (i.e. 
access to care, healthcare utilization, patient-provider communication)? Provide 
examples. 
13. What is most important when communicating recommendations or health advice 
to patients and the family (or immediate caregivers) of SCD patients? 
14. What are some of the most important recommendations given to SCD patients to 
achieve optimal health outcomes? 
15. How do you define success for you as a practitioner when dealing with SCD 
patients? 
16. What areas of improvement in healthcare and research do you feel are needed to 
improve health outcomes of SCD patients? 
 
 
